Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen

por Moazedi-Fuerst, FC, Kielhauser, SM, Brickmann, K, Hermann, J, Lutfi, A, Meilinger, M, Brezinschek, HP, Graninger, WB
Publicado 2014